Blog

Research!America is dedicated to ensuring a strong public and private sector investment in research to improve health at a level warranted by scientific opportunity and supported by public opinion. Member organizations and others share their perspectives on a wide variety of topics relating to public and private sector research and innovation, and public health. The views expressed by contributors are their own and not the view of Research!America.

Recent Blog Posts

The United Nations Foundation is an unwavering supporter of global health, from prevention of malaria deaths to polio eradication (in partnership with Research!America, the Global Health Council and others the UN Foundation held a briefing about the importance of the polio vaccine in 2011). With support from Johnson & Johnson and the Bill & Melinda Gates Foundation, their latest initiative is the Global Mom Relay, an innovative campaign to raise money and awareness in support of women and children’€™s health around the globe. Until May 8, there will be a daily story about motherhood on the Huffington Post from a variety of global authors. Each time a relay post is shared via...
Dear Research Advocate, Congress has passed a spending bill for what remains of the current fiscal year, which ends September 30. Preliminary agency funding levels have been reported by Nature . The appropriations process remains important for making up some small amount of the ground lost to sequestration, but as long as sequestration remains the law of the land, annual cuts to NIH, FDA and our nation’€™s other health research agencies are all but assured ; and with it, the insidious ripple effect of damage to grantees, vendors, and the pharma, bio and device industries that partner with researchers to develop the products patients await. That’€™s the bottom line. We must remind our...
A few weeks ago, we wrote about a Mississippi toddler who was "€œfunctionally cured"€ of HIV. Now, there is one more reason to celebrate: French researchers identified 14 adults who have been functionally cured of HIV as well. The adults received antiviral treatment within a few months of infection, but all stopped treatment at some point for a variety of reasons. Despite discontinued treatment, researchers found that these adults had extremely low levels of HIV and that their immune systems were controlling the infection without drugs. Although further research is necessary, scientists hope that other adults may be able to cease antiviral treatment and live healthily without drugs. This...
As sequestration threatens to obstruct progress in biomedical and health research, members of the research community are continuing to speak out against these across-the-board spending cuts. Research!America Board member Larry Shapiro, MD , dean of the Washington University School of Medicine in St. Louis’€™, shared his concerns in an article from the Associated Press. At Washington University in St. Louis and other research institutions across the country, ’€œautomatic cuts are causing anxiety among young researchers who are wondering what career options they’€™ll have if the current economic climate becomes ’€˜the new normal,’€™’€ according to the article. ’€This is all that’€™s being...
A new report from the Alzheimer’€™s Association reveals that one in three seniors suffer from some form of dementia or Alzheimer’€™s by their death. Deaths attributed to Alzheimer’€™s and dementia have increased 68% from 2000 to 2010. Harry Johns, president and CEO of the Alzheimer’€™s Association and Research!America Board member, said in an Alzheimer’€™s Association release that ’€œurgent, meaningful action is necessary, particularly as more and more people age into greater risk for developing a disease that today has no cure and no way to slow or stop its progression.’€ USA Today reports that the number of people with Alzheimer’€™s disease is expected to nearly triple by 2050, resulting...
Research!America extends our congratulations again to all of our 2013 Advocacy Award winners. The dinner was a wonderful opportunity to thank our supporters and advocates for all of their hard work and recognize leaders in the research and advocacy communities. This year’€™s Advocacy Award winners were Sen. Richard Burr (R-NC); Sen. Bob Casey (D-PA); John F. Crowley, patient advocate and chairman and CEO of Amicus Therapeutics, Inc.; Mark Rosenberg, MD, president and CEO of The Task Force for Global Health; John Mendelsohn, MD, director of the Khalifa Institute for Personalized Cancer Therapy and former president at The University of Texas MD Anderson Cancer Center; Diane Rehm, host of ’€œ...
Now available online, Research!America’€™s Annual Report, ’€œReasons for Research,’€ recounts the progress made in research advocacy by Research!America and its members representing academia, industry, scientific societies, patient groups and foundations. In addition to highlighting the 2012 Advocacy Awardees and Garfield Economic Impact Awardees, the report details Research!America initiatives such as the ongoing Save Research campaign and the Your Candidates’€“Your Health national voter education initiative. The annual report also includes polling data, statements from speakers at the National Health Research Forum ’€” including the heads of the federal health agencies ’€” and other...
From left: Karen Goraleski, LeAnne Fox, Kristy Murray, Brian D’€™Cruz, Rachel Cohen, Mark Rosenberg On March 14, Research!America hosted a neglected tropical disease panel at the Consortium of Universities for Global Health (CUGH) conference, ’€œAre NTDs a Growing Threat? Research, Access and Next Steps.’€ The conversation was moderated by Karen Goraleski, Executive Director of the American Society of Tropical Medicine and Hygiene (ASTMH) and featured the following panelists: Rachel Cohen, Regional Executive Director of the Drugs for Neglected Diseases initiative (DNDi); Brian D’€™Cruz, Emergency Physician with Doctors Without Borders/Médecins Sans Frontières North America; LeAnne Fox,...
Dear Research Advocate, Today, the Senate is planning to vote on a bipartisan continuing resolution from Sens. Mikulski and Shelby to fund the federal government through the end of the year. The good news is that the bill includes an increase, albeit small ($71 million) in NIH funding; Senator Harkin tried, unsuccessfully, unfortunately, to increase NIH even further, and Senator Durbin worked on an ambitious amendment to add more than $1.5 billion to the NIH budget. We truly appreciate the efforts of all of these champions and the fact that NIH funding was singled out for an increase on a bipartisan basis by the Appropriations Committee. The bad news is that sequestration will wipe out all...
Research!America will honor extraordinary leaders in biomedical and health research advocacy at the 17th Annual Advocacy Awards tonight, March 13, at the Andrew W. Mellon Auditorium in Washington, DC. This year’€™s Advocacy Award Winners are: Sens. Richard Burr (R-NC) and Bob Casey (D-PA); Diane Rehm, author and host of WAMU 88.5 and NPR’€™s ’€œThe Diane Rehm Show’€; John F. Crowley, patient advocate, inspirational entrepreneur, and chairman and CEO of Amicus Therapeutics, Inc.; John Mendelsohn, MD, director, Khalifa Institute for Personalized Cancer Therapy and former president of The University of Texas MD Anderson Cancer Center; Mark Rosenberg, MD, president and CEO, The Task Force for...

Pages

The capabilities are enormous, a little bit of research can pay off quite a bit in the long run.
Paul D’ Addario, retinitis pigmentosa patient